logo

FDA Calendar

Share
Company Name Heron Therapeutics Inc.
Drug Name HTX-011 (Resubmitted NDA)
Event Name FDA decision on HTX-011 for the management of postoperative pain
Event Date 06/26/2020
Outcome Date
Outcome
Drug Status Original FDA decision of March 26, 2020, extended to June 26, 2020
Rival Drugs
Market Potential
Other Approvals
News
Return to FDA Calendar

>